Webinar

Exploring New Frontiers in Direct to Patient Home Delivery Services for Clinical Trials Materials

Format: External webinar | Document type: Webinar

Exploring New Frontiers in Direct to Patient Home Delivery Services for Clinical Trials Materials
Exploring New Frontiers in Direct to Patient (DTP) Home Delivery Services for Clinical Trial Materials provides an in-depth look at reasons to consider a DTP solution. Included in the discussion are concerns with the traditional distribution channels, advantages and challenges of a DTP service solution, regulatory considerations when planning a global project, and insight into efficiently collaborating with partnering networks.  Leslie joined Marken in 2011 with an extensive background in the life sciences and early drug development. She has led the development of Marken's direct to patient delivery services to support human clinical trials. Leslie earned her PhD in Pharmacology and Toxicology from the University of Mississippi Medical Center, Jackson, MS, and is certified by the American Board of Toxicology. She was employed as a toxicologist and study director for the U.S Army’s Center for Health Promotion and Preventive Medicine, and for Therimmune Research. Prior to joining Marken, she was a leader in business development for GeneLogic, Xceleron, Inc., Harlan Laboratories, and the Battelle Memorial Institute.

Speaker

Leslie Chaney Leslie Chaney Global Director, Preclinical and Direct to Patient Services
Marken

Latest content from Marken

show more

How personalized medicines are disrupting the supply chain

Content provided by Marken

How personalized medicines are disrupting the supply chain

Sponsors for a Phase 2 clinical trial needed an expensive, time-sensitive therapy transported to investigator sites at -80º C. Further, when reaching out to cryogenic shipper rental companies, the sponsor found they often transport regionally and do not...

Marken Advances Critical Supply Chain

Content provided by Marken

Marken Advances Critical Supply Chain

Cell and gene therapies are the next-generation healthcare protocols, and the human trials into their efficacies are rising. An advanced supply chain solutions provider is the key to success.

Related resources from Marken

Show more

Supplier info centre